Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Associations between polymorphisms of DMA and
DMB
alleles and
systemic lupus erythematosus
(
SLE
) were studied in 51 Japanese
SLE
patients and 77 normal subjects by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Phenotype frequencies of DMB*0101 tended to increase in
SLE
, but the difference was not significant (76.5% vs 70.1% in controls). The phenotype frequency of DMB*0103 was decreased in the
SLE
group, but the difference was not significant (49.0% vs 53.2%). Furthermore, there was no evidence of any association of either DMA or
DMB
alleles with HLA-DRB1*1501. The phenotype frequency of DMB*0101 was higher in the
SLE
group with anti-double-stranded DNA antibody (a-dsDNA) than in the
SLE
group without a-dsDNA, but the difference was not significant (P = 0.045, corrected P not significant). No other DMA or
DMB
alleles showed any associations in various immunological subgroups of
SLE
. These data suggest that neither the DMA nor the
DMB
gene determines susceptibility to
SLE
in Japanese.
...
PMID:Polymorphisms of DMA and DMB genes in Japanese systemic lupus erythematosus. 948 57